×
验证码:
换一张
忘记密码?
记住我
CORC
首页
科研机构
检索
知识图谱
申请加入
托管服务
登录
注册
在结果中检索
科研机构
中国医学科学院 北... [21]
复旦大学上海医学院 [4]
四川大学 [3]
湖南大学 [3]
西安交通大学 [2]
吉林大学白求恩第一医... [2]
更多...
内容类型
期刊论文 [36]
发表日期
2019 [36]
×
知识图谱
CORC
开始提交
已提交作品
待认领作品
已认领作品
未提交全文
收藏管理
QQ客服
官方微博
反馈留言
浏览/检索结果:
共36条,第1-10条
帮助
限定条件
发表日期:2019
内容类型:期刊论文
已选(
0
)
清除
条数/页:
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
95
100
排序方式:
请选择
作者升序
作者降序
题名升序
题名降序
发表日期升序
发表日期降序
提交时间升序
提交时间降序
Safety and activity of sintilimab in patients with relapsed or refractory classical Hodgkin lymphoma (ORIENT-1): a multicentre, single-arm, phase 2 trial
期刊论文
LANCET HAEMATOLOGY, 2019, 卷号: 6, 期号: 1
作者:
Zhang, Wei
;
Gao, Yuhuan
;
Jin, Zhengming
;
Zhou, Jianfeng
;
Jin, Chuan
收藏
  |  
浏览/下载:46/0
  |  
提交时间:2019/12/05
Primary breast diffuse large B-cell lymphoma in the rituximab era: therapeutic strategies and patterns of failure (vol 109, pg 3943, 2018)
期刊论文
CANCER SCIENCE, 2019, 卷号: 110, 期号: 4
作者:
Xiao, Xiubin
;
Bao, Huizheng
;
Wang, Ningju
;
Ren, Hanyun
;
Cen, Xinan
收藏
  |  
浏览/下载:59/0
  |  
提交时间:2019/12/05
Nivolumab Versus Docetaxel in a Predominantly Chinese Patient Population With Previously Treated Advanced NSCLC: CheckMate 078 Randomized Phase III Clinical Trial
期刊论文
JOURNAL OF THORACIC ONCOLOGY, 2019, 卷号: 14, 期号: 5
作者:
Wu, Yi-Long
;
Lu, Shun
;
Cheng, Ying
;
Zhou, Caicun
;
Wang, Jie
收藏
  |  
浏览/下载:31/0
  |  
提交时间:2019/12/05
Chinese population
Nivolumab
NSCLC
Phase III clinical study
Pralatrexate in Chinese Patients with Relapsed or Refractory Peripheral T-cell Lymphoma: A Single-arm, Multicenter Study
期刊论文
TARGETED ONCOLOGY, 2019, 卷号: 14, 期号: 2
作者:
Hong, Xiaonan
;
Song, Yuqin
;
Huang, Huiqiang
;
Bai, Bing
;
Zhang, Huilai
收藏
  |  
浏览/下载:23/0
  |  
提交时间:2019/12/05
CMAB009 plus irinotecan versus irinotecan-only as second-line treatment after fluoropyrimidine and oxaliplatin failure in KRAS wild-type metastatic colorectal cancer patients: promising findings from a prospective, open-label, randomized, phase III trial
期刊论文
CANCER COMMUNICATIONS, 2019, 卷号: 39
作者:
Shi, Yuankai
;
Li, Jin
;
Xu, Jianming
;
Sun, Yan
;
Wang, Liwei
收藏
  |  
浏览/下载:114/0
  |  
提交时间:2019/12/05
CMAB009
Cetuximab
Irinotecan
Second-line
mCRC
EGFR
KRAS
Immunogenicity
Fluoropyrimidine
Oxaliplatin failure
VTE Risk Profiles and Prophylaxis in Medical and Surgical Inpatients The Identification of Chinese Hospitalized Patients' Risk Profile for Venous Thromboembolism (DissolVE-2)-A Cross-sectional Study
期刊论文
CHEST, 2019, 卷号: 155, 期号: 1
作者:
Zhai, Zhenguo
;
Kan, Quancheng
;
Li, Weimin
;
Qin, Xinyu
;
Qu, Jieming
收藏
  |  
浏览/下载:61/0
  |  
提交时间:2019/12/05
China
prophylaxis
risk profile
VTE
VTE Risk Profiles and Prophylaxis in Medical and Surgical Inpatients The Identification of Chinese Hospitalized Patients' Risk Profile for Venous Thromboembolism (DissolVE-2)-A Cross-sectional Study
期刊论文
CHEST, 2019, 卷号: 155, 页码: 114-122
作者:
Zhai, Zhenguo
;
Kan, Quancheng
;
Li, Weimin
;
Qin, Xinyu
;
Qu, Jieming
收藏
  |  
浏览/下载:61/0
  |  
提交时间:2019/11/19
VTE
prophylaxis
China
risk profile
Management of anlotinib-related adverse events in patients with advanced non-small cell lung cancer: Experiences in ALTER-0303.
期刊论文
Thoracic cancer, 2019, 卷号: 10, 页码: 551-556
作者:
Si Xiaoyan
;
Zhang Li
;
Wang Hanping
;
Zhang Xiaotong
;
Wang Mengzhao
收藏
  |  
浏览/下载:35/0
  |  
提交时间:2019/11/19
non-small cell lung cancer
multi-target tyrosine kinase inhibitor
Adverse event
anlotinib
Nivolumab Versus Docetaxel in a Predominantly Chinese Patient Population With Previously Treated Advanced Non-Small Cell Lung Cancer: CheckMate 078 Randomized Phase III Clinical Trial
期刊论文
Journal of Thoracic Oncology, 2019
作者:
Yi-Long Wu
;
Shun Lu
;
Ying Cheng
;
Caicun Zhou
;
Jie Wang
收藏
  |  
浏览/下载:15/0
  |  
提交时间:2019/02/25
Chinese
population
nivolumab
non-small
cell
lung
cancer
phase
III
clinical
study
VTE Risk Profiles and Prophylaxis in Medical and Surgical Inpatients: The Identification of Chinese Hospitalized Patients’ Risk Profile for Venous Thromboembolism —A Cross-sectional Study
期刊论文
Chest, 2019, 卷号: Vol.155 No.1, 页码: 114-122
作者:
Zhenguo Zhai
;
Quancheng Kan
;
Weimin Li
;
Xinyu Qin
;
Jieming Qu
收藏
  |  
浏览/下载:24/0
  |  
提交时间:2019/02/25
China
prophylaxis
risk
profile
VTE
©版权所有 ©2017 CSpace - Powered by
CSpace